Synaptics (SYNA) Form 3 SYNAPTICS / KERMIT NOLAN ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

NOLAN KERMIT

(Last) (First) (Middle)

1251 MCKAY DRIVE

(Street)

SAN JOSE CA 95131

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/07/2019

3. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	56,111(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(2)	08/03/2019	Common Stock	5,109(3)	25.5	D
Employee Stock Option (Right to Buy)	(4)	08/02/2020	Common Stock	13,000	31.73	D
Employee Stock Option (Right to Buy)	(5)	10/31/2019	Common Stock	1,000	23.16	D
Employee Stock Option (Right to Buy)	(6)	01/28/2020	Common Stock	1,000	35.76	D
Employee Stock Option (Right to Buy)	(7)	04/29/2020	Common Stock	1,000	42.57	D
Employee Stock Option (Right to Buy)	(8)	08/05/2020	Common Stock	1,000	39.8	D
Employee Stock Option (Right to Buy)	(9)	10/28/2020	Common Stock	744	46.5	D
Employee Stock Option (Right to Buy)	(10)	01/27/2021	Common Stock	744	60.22	D
Employee Stock Option (Right to Buy)	(11)	04/28/2021	Common Stock	744	61.4	D
Employee Stock Option (Right to Buy)	(12)	08/01/2021	Common Stock	745	78.11	D
Employee Stock Option (Right to Buy)	(13)	10/24/2021	Common Stock	408	62.105	D
Employee Stock Option (Right to Buy)	(14)	01/30/2022	Common Stock	408	76.81	D
Employee Stock Option (Right to Buy)	(15)	04/24/2022	Common Stock	408	85.69	D
Employee Stock Option (Right to Buy)	(16)	07/31/2022	Common Stock	408	79.38	D
Employee Stock Option (Right to Buy)	(17)	10/23/2022	Common Stock	1,049	89.29	D
Employee Stock Option (Right to Buy)	(18)	01/23/2023	Common Stock	1,050	73.31	D
Employee Stock Option (Right to Buy)	(19)	04/29/2023	Common Stock	1,049	71.55	D
Employee Stock Option (Right to Buy)	(20)	07/23/2023	Common Stock	1,050	51.95	D

Explanation of Responses:

1. Includes (i) 7,648 shares that were acquired upon delivery of vested deferred stock units, (ii) 17,531 shares underlying deferred stock units that are not yet vested and deliverable, and (iii) 1,354 shares released in connection with the vesting of performance-based market stock units granted on 12/13/17.

2. 25% of the 18,000 shares subject to the option vested and became exercisable on the 12 month anniversary of the 7/27/09 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 27th day of each month thereafter until fully vested on 7/27/13.

3. Does not include 12,891 shares underlying the option that were previously exercised.

4. 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the 8/02/10 date of grant until fully vested on 8/02/14.

5. 1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 10/31/12 date of grant until fully vested on 10/29/15.

6. 1/36th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month following the 1/28/13 date of grant until fully vested on 1/28/16.

7. 1/36th of the total number of shares subject to the option vested and became exercisable on the 29th day of each month following the 4/29/13 date of grant until fully vested on 4/29/16.

8. 1/36th of the total number of shares subject to the option vested and became exercisable on the 5th day of each month following the 8/05/13 date of grant until fully vested on 8/05/16.

9. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/28/13 date of grant until fully vested on 10/28/16.

10. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/27/14 date of grant until fully vested on 1/27/17.

11. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/28/14 date of grant until fully vested on 4/28/17.

12. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 8/01/14 date of grant until fully vested on 8/01/17.

13. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/24/14 date of grant until fully vested on 10/24/17.

14. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/30/15 date of grant until fully vested on 1/30/18.

15. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 4/24/15 date of grant until fully vested on 4/24/18.

16. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 7/31/15 date of grant until fully vested on 7/31/18.

17. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 10/23/15 date of grant until fully vested on 10/23/18.

18. 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the 1/29/16 date of grant until fully vested on 1/29/19.

19. 1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 4/29/16 date of grant until fully vested on 4/29/19.

20. 1/12th of the total number of shares subject to the option vested or shall vest and became exercisable or shall become exercisable each quarter following the 7/29/16 date of grant until fully vested on 7/29/19.

Remarks:

The reporting person is the Corporate Vice President, Chief Accounting Officer, and Interim Chief Financial Officer. Exhibit List Exhibit 24 - Limited Power of Attorney

	Kermit Nolan	02/11/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.